US103545A - Improved medical compound - Google Patents
Improved medical compound Download PDFInfo
- Publication number
- US103545A US103545A US103545DA US103545A US 103545 A US103545 A US 103545A US 103545D A US103545D A US 103545DA US 103545 A US103545 A US 103545A
- Authority
- US
- United States
- Prior art keywords
- improved medical
- medical compound
- compound
- philip
- becker
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title description 8
- 201000010099 disease Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 210000002816 Gills Anatomy 0.000 description 4
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000001258 Cinchona calisaya Nutrition 0.000 description 2
- 241000434299 Cinchona officinalis Species 0.000 description 2
- 235000006768 Cinchona succirubra Nutrition 0.000 description 2
- 244000182633 Cinchona succirubra Species 0.000 description 2
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 2
- 240000001238 Gaultheria procumbens Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 229960000948 Quinine Drugs 0.000 description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 2
- 244000299790 Rheum rhabarbarum Species 0.000 description 2
- 108060007338 SDHAF4 Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
Definitions
- This invention consists in a new compound of medicinal substances for the cure of fever and ague, and other kindred diseases, the said substances being as follows, mixed in the quantities, or thereabout, as stated: quinine, one dram; Peruvian bark, one ounce; rhubarb, one-half ounce; alcohol, one gill; water, one gill; winter-green, (liquid,) one tea-spoonful; molasses or sirup, (best,) one quart, to be mixed in a bottle and kept in a cool place, and to be administered about a half-hour before meals, three times a day, about a tablespoonful to a dose.
Description
UNITED STATES PATENT OFFICE.
PHILIP BECKER, OF SOUTH BETHLEHEM, PENNSYLVANIA.
IMPROVED MEDICAL COMPOUND.
Specification forming part of Letters Patent No. 103, 545, dated May 31, 1870.
To all whom it may concern:
Be it known that I, PHILIP BECKER, of South Bethlehem, in the county of N orthampton and State of Pennsylvania, have invented a new and Improved Medical Compound; and I do hereby declare that the following is a full, clear, and exact description thereof, which will enable others skilled in the art to make and use the same.
This invention consists in a new compound of medicinal substances for the cure of fever and ague, and other kindred diseases, the said substances being as follows, mixed in the quantities, or thereabout, as stated: quinine, one dram; Peruvian bark, one ounce; rhubarb, one-half ounce; alcohol, one gill; water, one gill; winter-green, (liquid,) one tea-spoonful; molasses or sirup, (best,) one quart, to be mixed in a bottle and kept in a cool place, and to be administered about a half-hour before meals, three times a day, about a tablespoonful to a dose.
If the medicine thus described is taken when the disease first sets in, three doses will be sufficient to check it; but it will be necessary to continue the cure a few days.
Before taking the medicine, and while taking it, a powerful physio should be taken to carry off the disease, according to the character and nature of the malady and the constitution of the patient. The use of the medicine should be continued from two to four days.
Having thus described my invention, I claim as new and desire to secure by Letters Patent- The improved medical compound, consisting of the above-described ingredients, mixed in about the proportions specified.
PHILIP BECKER.
WVitnesses:
H. J. REEDER, A. PoYoK, J AGOB 'ZoRN.
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US103545A true US103545A (en) | 1870-05-31 |
Family
ID=2173030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US103545D Expired - Lifetime US103545A (en) | Improved medical compound |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US103545A (en) |
-
0
- US US103545D patent/US103545A/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Coppen et al. | The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine | |
| Laine et al. | Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS: a randomized trial | |
| Diamond et al. | Ginkgo biloba extract: mechanisms and clinical indications | |
| Berning et al. | Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections. | |
| Cosgriff | The effectiveness of an oral vitamin K1 in controlling excessive hypoprothrombinemia during anticoagulant therapy | |
| US103545A (en) | Improved medical compound | |
| Munster et al. | Imipramine (Tofrānil) in the treatment of enuresis | |
| FR3021224A1 (en) | PHYTOMEDICAMENT FOR HIV | |
| Kaye | Clinical experiences with, and pharmacokinetics of, oxamniquine | |
| MAY et al. | Parkinsonian reactions following chlorpromazine and reserpine: Similar reactions in the same patients | |
| Kobusiewicz et al. | Management of severe atopic dermatitis in adult patients | |
| Goud et al. | Nimesulide-A drug to be banned completely | |
| US102686A (en) | Improvement in compounds for treating- rheumatism | |
| DENBER et al. | Problems in evaluation of R-1625 | |
| IL94601A (en) | Pharmaceutical compositions comprising naftopidil for therapy of dysuria | |
| EP0402208B1 (en) | Mixture of Vitamin A in physiological dosis and different active ingredients having therapeutic effect | |
| US113713A (en) | Improvement in medical compounds or bitters | |
| US116310A (en) | Improvement in medical compounds or bitters | |
| US117870A (en) | Improvement in medical compounds for treating rheumatism | |
| US118766A (en) | Improvement in medicines for treating rheumatism | |
| US57561A (en) | Improved medicine | |
| Kumari et al. | CHURNA KALPANA-A CLASSICAL AND CONTEMPORARY | |
| US90962A (en) | Improved medical compound | |
| US111655A (en) | Improvement in medical compounds | |
| US117065A (en) | Improvement in medicines for cure of hog and chicken cholera |